...
EHCLARGE

Encompass Health Corporation

HealthcareMedical - Care Facilities
$107.88
$0.01(+0.63%)
52W$92.53
$127.99
FinancialsValuationvs ENSG
Updated Mar 2, 12:00 AM
RSI56
RS Rating36/99
Beta0.49
Volatility28%
F-Score7/9
Mkt Cap$10.8B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Encompass Health Corporation is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 36), showing significant lag compared to the market leaders. Earnings growth of 17% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.

Relative Strength
36
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.49
vs S&P 500
LOW VOL
52W Position
43%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$103.86
50 SMA > 100 SMA$110.42
100 SMA > 150 SMA$114.05
150 SMA > 200 SMA$115.05

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$105.01+2.73%ABOVE
50 SMA$103.86+3.87%ABOVE
100 SMA$110.42-2.30%BELOW
150 SMA$114.05-5.41%BELOW
200 SMA$115.05-6.23%BELOW

Price Performance

1D+0.6%
1W+1.6%
1M+12.7%
3M-7.2%
6M-12.6%
YTD+1.4%
1Y+7.7%
3Y+24.0%
52-Week Trading Range43% from low
$107.88
52W Low$92.53
52W High$127.99

Technical Indicators

RSI (14)NEUTRAL
55.6
305070
VCP ScoreCOOL
6/10
Base depth: 21.3%

Risk Profile

Beta
0.49
52W Vol
28%
ATR
$3.33
Max DD (1Y)
-26%

Volume Analysis

Today
107
50D Avg
1.12M
Vol Ratio
0.00x
Liquidity
LIQUID

Earnings Momentum

Q4'24+37%
$1.18
Q1'25+35%
$1.48
Q2'25+24%
$1.39
Q3'25+17%
$1.24
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+6.66%
5 Years:+10.72%
3 Years:+10.92%
TTM:+11.13%

Compounded Profit Growth

10 Years:+11.26%
5 Years:+14.26%
3 Years:+27.15%
TTM:+27.78%

Stock Price CAGR

10 Years:+14.44%
5 Years:+11.16%
3 Years:+24.05%
1 Year:+7.73%

Return on Equity

10Y Avg:18.0%
5Y Avg:16.9%
3Y Avg:17.7%
Last Year:17.0%

Key Metrics

Market Cap$10.8B
Gross Margin47.5%
Net Margin9.5%
Piotroski F-Score7/9

More EHC Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

EHC vs ENSGENSGBKDNHCSEM

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 36 meansEHC outperformed 36% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.49 means 51% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 7/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 6/10 with COOL status.

Frequently Asked Questions

Is EHC in an uptrend right now?

EHC has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is EHC overbought or oversold?

EHC's RSI (14) is 56. The stock is in neutral territory, neither overbought nor oversold.

Is EHC outperforming the market?

EHC has a Relative Strength (RS) Rating of 36 out of 99. EHC is currently lagging the broader market.

Where is EHC in its 52-week range?

EHC is trading at $107.88, which is 84% of its 52-week high ($127.99) and 43% above its 52-week low ($92.53).

How volatile is EHC?

EHC has a Beta of 0.49 and 52-week volatility of 28%. It's less volatile than the S&P 500 - generally more stable.